Evaluation of Contrast-Enhanced Ultrasound in Human Crohn's Disease
Status: Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 16 Jun 2015
Price : $35 *
At a glance
- Drugs Perflutren (Primary)
- Indications Crohn's disease
- Focus Diagnostic use
- 12 Jun 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 08 Dec 2014 Planned initiation date changed from 1 Aug 2014 to 1 Feb 2015 as reported by ClinicalTrial.gov record.
- 05 Jun 2014 Planned initiation date changed from 1 Mar 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.